FDA — authorised 29 December 1998
- Application: ANDA064064
- Marketing authorisation holder: BAUSCH AND LOMB
- Indication: Manufacturing (CMC)
- Status: approved
🇺🇸 Cortisporin in United States
FDA authorised Cortisporin on 29 December 1998
Marketing authorisations
FDA — authorised 7 June 1999
- Application: ANDA064068
- Marketing authorisation holder: BAUSCH AND LOMB
- Indication: Manufacturing (CMC)
- Status: approved
FDA — authorised 27 June 2000
- Application: ANDA064046
- Marketing authorisation holder: BAUSCH AND LOMB
- Indication: Manufacturing (CMC)
- Status: approved
Cortisporin in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Infectious Disease approved in United States
Frequently asked questions
Is Cortisporin approved in United States?
Yes. FDA authorised it on 29 December 1998; FDA authorised it on 7 June 1999; FDA authorised it on 27 June 2000.
Who is the marketing authorisation holder for Cortisporin in United States?
BAUSCH AND LOMB holds the US marketing authorisation.